Showing results (101-110 of 112) with videos related to
Sort By:
Pageof 12
Plos One|July 1, 2014
Rs964184 (APOA5-A4-C3-A1) is related to elevated plasma triglyceride levels, but not to an increased risk for vascular events in patients with clinically manifest vascular diseaseAnton P van de Woestijne, Yolanda van der Graaf, Paul I W de Bakker, et al.Chinese Medical Journal|January 23, 2008
Fearful imagery induces hyperventilation and dyspnea in medically unexplained dyspneaJiang-na Han, Yuan-jue Zhu, Dong-mei Luo, et al.Occupational and Environmental Medicine|September 3, 1999
Acquisition and extinction of somatic symptoms in response to odours: a Pavlovian paradigm relevant to multiple chemical sensitivityO Van den Bergh, K Stegen, I Van Diest, et al.Current Medical Research and Opinion|December 18, 2007
ApoB/A1 and LDL-C/HDL-C and the prediction of cardiovascular risk in statin-treated patientsA H Liem, A P van de Woestijne, H W O Roeters van Lennep, et al.International Journal of Cardiology|January 24, 2012
Plasma triglyceride levels increase the risk for recurrent vascular events independent of LDL-cholesterol or nonHDL-cholesterolAnton P van de Woestijne, Annemarie M J Wassink, Houshang Monajemi, et al.Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|May 26, 2004
[Medically unexplained dyspnea in children: a review of 34 cases]Jiang-na Han, Yuan-jue Zhu, Shun-wei Li, et al.Psychophysiology|September 19, 2002
Guidelines for mechanical lung function measurements in psychophysiologyThomas Ritz, Bernhard Dahme, Arthur B Dubois, et al.European Journal of Clinical Investigation|November 21, 2013
LDL-c-linked SNPs are associated with LDL-c and myocardial infarction despite lipid-lowering therapy in patients with established vascular diseaseAnton P van de Woestijne, Yolanda van der Graaf, Paul I W de Bakker, et al.Chinese Medical Journal|January 22, 2004
Medically unexplained dyspnea: psychophysiological characteristics and role of breathing therapyJiang-na Han, Yuan-jue Zhu, Shun-wei Li, et al.International Journal of Cardiology|October 13, 2007
Effect of EPO administration on myocardial infarct size in patients with non-STE acute coronary syndromes; results from a pilot studyAnho Liem, Anton P van de Woestijne, Erik Bruijns, et al.Pageof 12